DrugPatentWatch Database Preview
DOPAMINE HYDROCHLORIDE Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
When do Dopamine Hydrochloride patents expire, and when can generic versions of Dopamine Hydrochloride launch?
Dopamine Hydrochloride is a drug marketed by Abbott, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hikma Intl Pharms, Hospira, Igi Labs Inc, Intl Medication, Lyphomed, Smith And Nephew, Teligent, Teva Parenteral, Warner Chilcott, and B Braun. and is included in thirty-six NDAs.
The generic ingredient in DOPAMINE HYDROCHLORIDE is dopamine hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Dopamine Hydrochloride
A generic version of DOPAMINE HYDROCHLORIDE was launched as dopamine hydrochloride by HOSPIRA on December 14th, 2019.
Summary for DOPAMINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 14 |
| NDAs: | 36 |
| Suppliers / Packagers: | 5 |
| Bulk Api Vendors: | 117 |
| Clinical Trials: | 826 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DOPAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for DOPAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| GCP unit, Copenhagen University Hospital | Phase 2 |
| Rigshospitalet, Denmark | Phase 2 |
| ACADIA Pharmaceuticals Inc. | Phase 2 |
Pharmacology for DOPAMINE HYDROCHLORIDE
| Drug Class | Catecholamine Plasma Volume Expander |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Intravascular Volume |
Medical Subject Heading (MeSH) Categories for DOPAMINE HYDROCHLORIDE
Synonyms for DOPAMINE HYDROCHLORIDE
| .beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride |
| (Dopamine HCl) |
| 1, 4-(2-aminoethyl)-, hydrochloride |
| 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride |
| 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride (1:1) |
| 1477-71-0 |
| 2-(3,4-dihydroxyphenyl)-ethylamine hydrochloride |
| 2-(3,4-dihydroxyphenyl)ethyl-1-13c-amine hcl |
| 2-(3,4-Dihydroxyphenyl)ethylamine hydrochloride |
| 2002410-63-9 |
| 3-Hydroxytyramine hydrochloride |
| 3-Hydroxytyramine hydrochloride, 99% |
| 3-Hydroxytyramine, HCl |
| 3-Hydroxytyramine, Hydrochloride |
| 3-hydroxytyraminium chloride |
| 3,4-dihydoxyphenethylamine hydrochloride |
| 3,4-Dihydroxyphenethylamine hydrochloride |
| 3,4-Dihydroxyphenethylamine, HCl |
| 3,4-dihydroxyphenyl-ethylamine hydrochloride |
| 3,4-dihydroxyphenylethylaminehydrochloride |
| 335081-04-4 |
| 4-(2-Aminoethyl)-1-2-benzenediol |
| 4-(2-Aminoethyl)-1,2-benzenediol hydrochloride |
| 4-(2-aminoethyl)benzene-1,2-diol hydrochloride |
| 4-(2-aminoethyl)benzene-1,2-diol, chloride |
| 4-(2-aminoethyl)benzene-1,2-diol,hydrochloride |
| 4-(2-aminoethyl)benzene-1,2-diol;hydrochloride |
| 4-(2-Aminoethyl)pyrocatechol hydrochloride |
| 51-61-6 (Parent) |
| 62-31-7 |
| 7L3E358N9L |
| 963AD780-3E96-47B5-9044-7E59F6C84D67 |
| A0305 |
| AB0013398 |
| AB1009239 |
| AB2000629 |
| Abbodop |
| AC-12190 |
| AC1L232Y |
| ACMC-1B1TV |
| Actopamin (TN) |
| AKOS008056421 |
| AM20080715 |
| AN-41839 |
| ASL 279 |
| ASL-279 |
| BC650941 |
| BCP06611 |
| beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride |
| C8H11NO2.HCl |
| Cardiosteril |
| CAS-62-31-7 |
| CCG-40211 |
| CHEBI:4698 |
| CHEMBL1557 |
| CPD000059081 |
| CS-2562 |
| CTENFNNZBMHDDG-UHFFFAOYSA-N |
| CTK2F3033 |
| D00633 |
| DB-023081 |
| Dopamine (hydrochloride) |
| Dopamine chloride |
| Dopamine Fresenius |
| Dopamine HCl |
| DOPAMINE HCL AND DEXTROSE 5% |
| DOPAMINE HCL AND DEXTROSE 5% IN PLASTIC CONTAINER |
| DOPAMINE HCL IN DEXTROSE 5% |
| DOPAMINE HCL IN DEXTROSE 5% IN PLASTIC CONTAINER |
| Dopamine HCl salt |
| Dopamine hydrochloride (Inotropin) |
| Dopamine hydrochloride (JP17/USP) |
| Dopamine hydrochloride [USAN:JAN] |
| Dopamine hydrochloride [USAN:USP:JAN] |
| Dopamine hydrochloride and dextrose 5% |
| Dopamine hydrochloride and dextrose 5% in plastic container |
| Dopamine hydrochloride in dextrose 5% |
| Dopamine hydrochloride in dextrose 5% in plastic container |
| Dopamine hydrochloride solution, 1.0 mg/mL in methanol with 5% 1 M HCl (as free base), ampule of 1 mL, certified reference material |
| Dopamine hydrochloride, British Pharmacopoeia (BP) Reference Standard |
| Dopamine hydrochloride, certified reference material, TraceCERT(R) |
| Dopamine hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Dopamine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material |
| Dopamine hydrochloride, puriss., >=98.5% (AT) |
| Dopamine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| dopamine hydrogen chloride |
| Dopamine, 3-Hydroxytyramine |
| Dopamine, 3-Hydroxytyramine hydrochloride |
| Dopamine.HCl |
| Dopamini hydrochloridum,(S) |
| Dopastat |
| DSSTox_CID_550 |
| DSSTox_GSID_20550 |
| DSSTox_RID_75655 |
| DTXSID7020550 |
| Dynatra |
| EINECS 200-527-8 |
| EU-0100586 |
| F0001-1648 |
| FT-0603260 |
| H 8502 |
| H976 |
| HMS1920I18 |
| HY-B0451A |
| IN1467 |
| Inotropin |
| intropin |
| Intropin (TN) |
| Intropin [as hydrochloride] |
| J10150 |
| KB-32250 |
| KS-00000JK7 |
| KS-5304 |
| KSC-10-159 |
| KSC353A3H |
| KUC104380C |
| LP00586 |
| LS-7371 |
| M-7455 |
| m-Hydroxytyramine hydrochloride |
| MCULE-8844188424 |
| MFCD00012898 |
| MLS000069419 |
| MLS001074180 |
| MolPort-001-769-140 |
| NC00545 |
| NCGC00093965-01 |
| NCGC00093965-02 |
| NCGC00093965-03 |
| NCGC00093965-04 |
| NCGC00258571-01 |
| NCGC00261271-01 |
| NSC 169105 |
| NSC-169105 |
| NSC-756749 |
| NSC169105 |
| NSC756749 |
| Opera_ID_218 |
| P 498 |
| Pharmakon1600-01500263 |
| PubChem22727 |
| Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride |
| Rascordin |
| Revivan |
| RTR-021420 |
| s2529 |
| SAM002554938 |
| SBB003668 |
| SC-16285 |
| SCHEMBL40951 |
| SGCUT00110 |
| SMR000059081 |
| SPECTRUM1500263 |
| SR-01000075366 |
| SR-01000075366-1 |
| SR-01000075366-8 |
| ST24023111 |
| SW199608-2 |
| Tensamin |
| to_000060 |
| Tox21_201018 |
| Tox21_500586 |
| TR-021420 |
| UNII-7L3E358N9L |
| W0031 |
| Z262221794 |
US Patents and Regulatory Information for DOPAMINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER | dopamine hydrochloride | INJECTABLE;INJECTION | 019099-003 | Oct 15, 1986 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Teligent | DOPAMINE HYDROCHLORIDE | dopamine hydrochloride | INJECTABLE;INJECTION | 018656-001 | Jun 28, 1983 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Hospira | DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | dopamine hydrochloride | INJECTABLE;INJECTION | 018826-003 | Sep 30, 1983 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Baxter Hlthcare | DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | dopamine hydrochloride | INJECTABLE;INJECTION | 019615-003 | Mar 27, 1987 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Lyphomed | DOPAMINE HYDROCHLORIDE | dopamine hydrochloride | INJECTABLE;INJECTION | 018549-001 | Mar 11, 1983 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
